BrainsWay Ltd.
Organization details
- Legal name
- BrainsWay Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Jerusalem
- Headquarters country
- Israel
- Ticker symbol
- BWAY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001505065
- Wikidata ID
- Q2913953
Board of directors
-
Abraham Zangen · DirectorSince 2026
-
Amiram Boehm · DirectorSince 2026
-
Avner Lushi · DirectorSince 2026
-
David Zacut · DirectorSince 2026
-
Jonathan K. Shulkin · DirectorSince 2026
-
Karen Sarid · DirectorSince 2026
-
Rayten Michal Ety Mitrany · DirectorSince 2026
Board connections
2 of this board's directors also sit on 2 other boards. 1 is in the same sector.
- via Amiram Boehm
-
Silexion Therapeutics Corp Same sectorvia Avner Lushi
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 7 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Open-market sale | −5,000 | — | — |
| Jun 2, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −1,000 | — | — |
| Jun 2, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| Jun 1, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| Jun 1, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| May 26, 2026 | Rayten Michal Ety Mitrany Director | Open-market sale | −7,980 | — | — |
| May 25, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Option exercise | +7,500 | — | — |
| May 25, 2026 | Rayten Michal Ety Mitrany Director | Open-market sale | −10,000 | — | — |
| May 25, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Shares withheld for tax | −1,902 | — | — |
| May 20, 2026 | Rayten Michal Ety Mitrany Director | Option exercise | +17,500 | — | — |
| May 20, 2026 | Rayten Michal Ety Mitrany Director | Shares withheld for tax | −6,080 | — | — |
| May 19, 2026 | Rayten Michal Ety Mitrany Director | Option exercise | +10,000 | — | — |
| May 19, 2026 | Rayten Michal Ety Mitrany Director | Shares withheld for tax | −3,440 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about BrainsWay Ltd.
How many directors are on BrainsWay Ltd.'s board?
BrainsWay Ltd.'s board has 7 directors: Abraham Zangen, Amiram Boehm, Avner Lushi, David Zacut, Jonathan K. Shulkin, Karen Sarid and Rayten Michal Ety Mitrany.
Are BrainsWay Ltd. insiders buying or selling shares?
Over the last 12 months, BrainsWay Ltd. insiders made no open-market purchases and sold $0 of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="brainsway-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.